Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Thursday, April 30, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
Merck KGaA Doses First Patient in Phase 3 Lupus Skin Study
Life Sciences Times
-
April 30, 2026
Pharma
Newron Reports FDA Hold on New Enrollment at U.S. Sites in Schizophrenia Study
Life Sciences Times
-
April 30, 2026
Pharma
Verastem Oncology Launches Campaign for KRAS-Mutated Recurrent Ovarian Cancer Treatment
Life Sciences Times
-
April 30, 2026
Pharma
Chiesi Group to Acquire KalVista Pharmaceuticals in $1.9 Billion Deal
Life Sciences Times
-
April 29, 2026
Pharma
FDA Accepts New Drug Application for Zipalertinib in EGFR-Mutated Lung Cancer
Life Sciences Times
-
April 28, 2026
Pharma
Blackstone Life Sciences, Johnson & Johnson Partner to Fund AML Drug Development
Life Sciences Times
-
February 23, 2026
0
Pharma
Meta-Analysis Links Trial Assessment Frequency to Placebo Response in Anxiety Studies
Life Sciences Times
-
February 20, 2026
0
Pharma
FDA Approves Calquence–Venetoclax Combination as First All-Oral Fixed-Duration Option for Newly Diagnosed CLL
Life Sciences Times
-
February 20, 2026
0
Pharma
Affinia Therapeutics Wins EMA Orphan Drug Status for Gene Therapy in Rare Genetic Heart Disease
Life Sciences Times
-
February 18, 2026
0
Pharma
Vyome Reports Positive Preclinical Results for VT-1908 in Uveitis, Highlighting Potential $3B Market Opportunity
Life Sciences Times
-
February 18, 2026
0
Pharma
FDA Accepts Tirabrutinib NDA for Relapsed or Refractory PCNSL, Sets December 2026 Decision Date
Life Sciences Times
-
February 17, 2026
0
Pharma
Phase III KALOS and LOGOS Trial Results for BREZTRI in Uncontrolled Asthma Published in The Lancet Respiratory Medicine
Life Sciences Times
-
February 13, 2026
0
Pharma
FDA Approves Pembrolizumab-Based Regimens for Certain Patients With Platinum-Resistant Ovarian Cancer
Life Sciences Times
-
February 11, 2026
0
Pharma
Vyome Seeks Orphan Drug Designation for VT-1953 as Company Prioritizes Program Development
Life Sciences Times
-
February 11, 2026
0
Pharma
Stoke Therapeutics Doses First Patient in Early-Stage Study of Experimental Treatment for Inherited Vision Disorder
Life Sciences Times
-
February 11, 2026
0
Pharma
FDA accepts Takeda’s narcolepsy drug application, grants priority review for oveporexton
Life Sciences Times
-
February 10, 2026
0
Pharma
PharmaEssentia Plans New Puerto Rico Manufacturing Facility to Support Global Growth of BESREMi®
Life Sciences Times
-
February 9, 2026
0
1
...
3
4
5
...
91
Page 4 of 91
Most Read
Merck KGaA Doses First Patient in Phase 3 Lupus Skin Study
April 30, 2026
Johnson & Johnson Names Ryan Koors Vice President of Investor Relations
April 30, 2026
Moleculent Raises $20 Million to Expand Functional Profiling Platform
April 30, 2026
Komodo Health Names Paul Thomas Chief Financial Officer
April 30, 2026